Familial hypocalciuric hypercalcemia historical perspective: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
==Historical Perspective== | ==Historical Perspective== | ||
===Discovery=== | |||
* In the year 1966 FHH was first described by Jackson and Boonstra in a hypercalcemic patient presumed to have Hyperparathyroidism. He wasn't cured despite the removal of three and a half hyperplastic parathyroid glands. Subsequently, seventeen family members with hypercalcemia were identified in three generations<ref name="urlThe relationship of hereditary hyperparathyroidism to endocrine adenomatosis - ScienceDirect">{{cite web |url=http://www.sciencedirect.com/science/article/pii/0002934367901143?via%3Dihub |title=The relationship of hereditary hyperparathyroidism to endocrine adenomatosis - ScienceDirect |format= |work= |accessdate=}}</ref><ref name="urlFamilial Hypocalciuric Hypercalcemia | SpringerLink">{{cite web |url=https://link.springer.com/article/10.1023/A%3A1026566418011 |title=Familial Hypocalciuric Hypercalcemia | SpringerLink |format= |work= |accessdate=}}</ref>. | * In the year 1966 FHH was first described by Jackson and Boonstra in a hypercalcemic patient presumed to have Hyperparathyroidism. He wasn't cured despite the removal of three and a half hyperplastic parathyroid glands. Subsequently, seventeen family members with hypercalcemia were identified in three generations<ref name="urlThe relationship of hereditary hyperparathyroidism to endocrine adenomatosis - ScienceDirect">{{cite web |url=http://www.sciencedirect.com/science/article/pii/0002934367901143?via%3Dihub |title=The relationship of hereditary hyperparathyroidism to endocrine adenomatosis - ScienceDirect |format= |work= |accessdate=}}</ref><ref name="urlFamilial Hypocalciuric Hypercalcemia | SpringerLink">{{cite web |url=https://link.springer.com/article/10.1023/A%3A1026566418011 |title=Familial Hypocalciuric Hypercalcemia | SpringerLink |format= |work= |accessdate=}}</ref>. | ||
Revision as of 14:59, 21 September 2017
|
Familial hypocalciuric hypercalcemia Microchapters |
|
Differentiating Familial Hypocalciuric Hypercalcemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Familial hypocalciuric hypercalcemia historical perspective On the Web |
|
American Roentgen Ray Society Images of Familial hypocalciuric hypercalcemia historical perspective |
|
FDA on Familial hypocalciuric hypercalcemia historical perspective |
|
CDC on Familial hypocalciuric hypercalcemia historical perspective |
|
Familial hypocalciuric hypercalcemia historical perspective in the news |
|
Blogs on Familial hypocalciuric hypercalcemia historical perspective |
|
Risk calculators and risk factors for Familial hypocalciuric hypercalcemia historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ajay Gade MD[2]]
Overview
Historical Perspective
Discovery
- In the year 1966 FHH was first described by Jackson and Boonstra in a hypercalcemic patient presumed to have Hyperparathyroidism. He wasn't cured despite the removal of three and a half hyperplastic parathyroid glands. Subsequently, seventeen family members with hypercalcemia were identified in three generations[1][2].
- A similar family was identified in the year 1972 by Foley Et al. The family members of both the families were asymptomatic and hypercalcemic which is very typical of FHH[2].
- In 1990 ten cases of pancreatitis were reported in patients with family members of FHH[3].
- In 1990 NIH held conference to establish the principles for diagnosing and surgical vs medical management guidelines for FHH[4].
- In 1993 Brown Et al identified a bovine parathyroid cell Calcium sensing receptor cDNA by expression cloning in Xenopus laevis oocytes. The cDNA encoded a predicted 120-kD polypeptide containing a large extracellular domain and 7 membrane-spanning regions characteristic of G protein-coupled cell surface receptors. In addition to parathyroid tissue, It also identified the presence of CASR in regions of the kidney involved in Calcium regulated Calcium and Magnessium reabsorption[5].
- In 1995 studies were conducted to characterize the mutations of Calcium sensing mutations in FHH and Neonatal hyperparathyroidism[6].
References
- ↑ "The relationship of hereditary hyperparathyroidism to endocrine adenomatosis - ScienceDirect".
- ↑ 2.0 2.1 "Familial Hypocalciuric Hypercalcemia | SpringerLink".
- ↑ "Familial hypocalciuric hypercalcaemia and pancreatitis: no causal link proven - Stuckey - 1990 - Internal Medicine Journal - Wiley Online Library".
- ↑ "Summary Statement from a Workshop on Asymptomatic Primary Hyperparathyroidism: A Perspective for the 21st Century | The Journal of Clinical Endocrinology & Metabolism | Oxford Academic".
- ↑ "Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid".
- ↑ "Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism".